The CF community has entered the era of highly effective CF transmembrane conductance regulator (CFTR) modulator therapy (HEMT), in which widespread use of HEMT is changing CF disease in unprecedented ways that will require complementary changes in how CF is managed for many people (56). Here, CFTR is linked to cystic fibrosis.